Blueprint MedTech Awards

Blueprint MedTech Awardees

NIH’s Blueprint MedTech program has issued eight Optimizer project awards from its first competition cycle. The first round of these awards totals $11M. These projects will be administered by the two Blueprint MedTech Incubator Hubs—CIMIT’s Center for Innovative NeuroTech Advancement (CINTA) and NeuroTech Harbor (NTH).

In addition to the Innovator awards, Blueprint MedTech is extending Seedling awards to 17 innovators whose applications represented special merit but were not quite ready for a larger development award. Seedling awards provide support for six months, a $25,000 stipend, and $25,000 to hire subject matter experts. For these, mentors will work with awardees to help resolve specifically identified gap(s) on the path to commercialization. Each of these awardees also has access to $50,000 of in-kind support via mentoring, regulatory consulting, and other commercialization training.

Finally, Blueprint MedTech also has Translator project awards made via UG3/UH3 and U44 cooperative agreement funding mechanisms after NIH grant review. We have listed the first four awards made via these funding mechanisms below as well.

Blueprint MedTech Cycle 1 Optimizer awardees:

For additional details on the Optimizer awards, please see this NIBIB Science Highlight.

Awardee InstitutionOptimizer Project TitleFunding NIH Institute(s)
Icahn School of Medicine at Mount Sinai, New York; University of California, San Diego; and Johns Hopkins University, BaltimoreMonOsNIDA
NeuraStasis, Inc., Houston*Development/Testing of BlueStem Dual Nerve Stimulation Device for Ischemic StrokeNINDS
Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton*External focused ultrasound modulation of the dorsal root gangliaNIDA and NINDS
Endovascular Horizons and University of California San FranciscoEmbodrain technology for chronic subdural hematomasNINDS
Boston University and Harvard University, Boston*reNeu propulsion rehabilitation platform for gait restoration after neurological diseaseNICHD/National Center for Medical Rehabilitation Research (NCMRR), and NINDS
Northern Arizona University and Biomotum, Inc., FlagstaffA wearable rehabilitation robot for children to use at homeNINDS
Openwater, Inc., San FranciscoWearable noninvasive, transcranial focused ultrasound neuromodulation with near-infrared optical neuromonitoringBRAIN Initiative
SecondWave Systems, Inc., MinneapolisTreatment of Facial Pain using an Injectable Ultrasonically Powered NeurostimulatorNIDCR
Battelle Memorial Institute, ColumbusAt-home, closed-loop vagus nerve stimulation system to restore hand function in individuals with strokeNINDS

*participant in the 2022 Blueprint MedTech pilot

Blueprint MedTech Cycle 1 Seedling awardees (see descriptions from the Neurotech Harbor web page):

Awardee InstitutionSeedling Project TitleFunding NIH Institute(s)
UCSF, San FranciscoAn Implantable Closed-Loop Neuromodulation Device for Neuropsychiatric DisordersBRAIN Initiative
Lundquist Institute, Los AngelesEndovascular Electrode Device for Transvenous ElectroencephalographyBRAIN Initiative
Johns Hopkins University, MarylandPhotoacoustic Retinal ProsthesisNEI
Asayena, Inc., La JollaNeuromodulation Device for Restoration of Motor FunctionNICHD/NCMRR
MIT, CambridgeMagnetomicrometryNICHD/NCMRR, NINDS
Motif Neurotech, Inc., HoustonMinimally Invasive Implants for Treatment-Resistant DepressionBRAIN Initiative
UNandUP, LLC, St.LouisMagneto-Thrombolysis to Improve Acute Ischemic Stroke CareNINDS
JUAD Neurotech, IrvineMinimally Invasive Device for Epilepsy SurgeryNINDS, BRAIN Initiative
Longeviti Neuro Solutions, BaltimoreMonitoring GBM Through Implantable Ultrasound TransducerNINDS
Johns Hopkins University, BaltimoreA Non-Invasive Imaging Device to Modernize Treatment of Peripheral Nerve InjuriesNINDS
FemiStim, Gainesville FloridaFemiStim, the Sexual Health Neurostimulator for Victims of Female Genital MutilationNINDS
Arizona State University, PhoenixWireless, Injectable Neurostimulators (WINS) for Treating Chronic Migraine (CM)NINDS
University of Utah, Salt Lake CityDrug Delivering Nervewrap for Peripheral Nerve RegenerationNINDS
Neuroview Technology, Inc., Englewood, New JerseySubgaleal Hyper-chronic EEG Monitoring PlatformNINDS
Johns Hopkins University, BaltimoreDevelopment of a Smart Cerebrospinal Fluid Management Implant in Patients with Spinal Cord InjuryNINDS
Johns Hopkins University, BaltimoreImplantable Ultrasound Transducer for Remote Spinal Cord Injury MonitoringNINDS
MacHouse Designs, LLC, Loveland, ColoradoIn vivo Visualization of Peripheral Nerves Using Novel CT Contrast AgentsNIDCR

BPMT Translator Awards:

The Blueprint MedTech program also has Translator Cooperative Agreement awards,  Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional), PAR-21-315 and Blueprint MedTech: Small Business Translator (U44 - Clinical Trial Optional), PAR-21-282. The following awards have been made in these programs to date:

  • U44 DA059380-01   John Konsin, PI, Prapela, Inc.  ​ 
    • Prapela® SVS incubator pad: A cost-effective stochastic vibrotactile device to improve the clinical course of infants with apnea of prematurity 
  • U44 NS136026-01A1  (BRAIN NOSI) Haidong Peng, PI, Neuro42, Inc. ​  
    • Portable Intraoperative MRI for Neurosurgery
  • UG3 NS130338-01A1   Richard Webb, PI, Rhaeos, Inc. 
    • Development of wireless, wearable flow sensors for continuous, long-term tracking of cerebrospinal fluid dynamics in patients with hydrocephalus
  • UG3 NS135551-01 (HEAL NOSI)   Charles Caskey, PI, Vanderbilt University Medical Center 
    • Translating an MR-guided focused ultrasound system for first-in-human precision neuromodulation of pain circuits
  • U44 DA060264-01 Xiaofeng Xia, PI, Instanosis, Inc.
    • Addressing Emerging Drug Threats with InstaStrip Rapid Tests
  • U44 DA059627-01 Patrik Schmidle, PI, Cari Health, Inc.
    • Methadone Dosing System (MDS)